Literature DB >> 2385335

Clinical and pathological analysis of spinal cord astrocytomas in children.

E Rossitch1, S M Zeidman, P C Burger, J T Curnes, C Harsh, M Anscher, W J Oakes.   

Abstract

Twelve children with pathologically confirmed, well-differentiated spinal cord astrocytomas were studied, and correlations among the degree of resection, pathological characteristics, and time of recurrence were examined. Eight tumors were sampled for biopsy or subtotally resected, and 4 were thought to have been totally removed. Clinical recurrence was seen in 4 of 12 patients, 2 of whom died of their disease. The time to recurrence was 1, 2, 2, and 35 years, respectively. The other 8 children remain free of symptoms, with follow-up ranging from 6 months to 35 years (mean, 8.8 years). In 3 of 8 patients who underwent biopsy or subtotal resection, the tumor recurred, and 2 patients died, whereas there was one recurrence in the patients in whom a "total" resection had been obtained. The histologically well-differentiated nature of the lesions correlated well with the relatively prolonged clinical course seen in this series during the period of observation. The relatively long clinical courses seen in our limited series should be considered before high-risk therapy for spinal cord astrocytomas in children is implemented. The presence of four pilocytic astrocytomas in this group was of special interest, and it seems likely that these discrete neoplasms can be distinguished from the more infiltrating fibrillary astrocytic neoplasms by magnetic resonance imaging with enhancement with gadopentetate dimeglumine.

Entities:  

Mesh:

Year:  1990        PMID: 2385335     DOI: 10.1097/00006123-199008000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

Review 1.  Radiation therapy and the management of intramedullary spinal cord tumors.

Authors:  S R Isaacson
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

3.  Surgery of intramedullary spinal cord tumors.

Authors:  M Zileli; E Coşkun; N Ozdamar; I Ovül; E Tunçbay; K Oner; N Oktar
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

4.  Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database.

Authors:  Birte Wolff; Ann Ng; Daniela Roth; Kathleen Parthey; Monika Warmuth-Metz; Matthias Eyrich; Uwe Kordes; Rolf Kortmann; Torsten Pietsch; Christof Kramm; Johannes Ea Wolff
Journal:  J Neurooncol       Date:  2011-10-01       Impact factor: 4.130

5.  Intramedullary spinal cord astrocytoma in adults: postoperative outcome.

Authors:  M S Kim; C K Chung; G Choe; I H Kim; H J Kim
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

6.  Intramedullary low-grade astrocytomas: long-term outcome following radical surgery.

Authors:  G I Jallo; S Danish; L Velasquez; F Epstein
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

7.  Surgical pathology of intramedullary spinal cord neoplasms.

Authors:  D C Miller
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

8.  Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Authors:  Mohamad H Fakhreddine; Anita Mahajan; Marta Penas-Prado; Jeffrey Weinberg; Ian E McCutcheon; Vinay Puduvalli; Paul D Brown
Journal:  Neuro Oncol       Date:  2013-01-14       Impact factor: 12.300

9.  Pediatric primary high-grade spinal glioma: a National Cancer Database analysis of current patterns in treatment and outcomes.

Authors:  Ravi S Nunna; Syed Khalid; Mandana Behbahani; Ankit I Mehta
Journal:  Childs Nerv Syst       Date:  2020-06-12       Impact factor: 1.475

10.  Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival.

Authors:  John R Crawford; Alejandra Zaninovic; Mariarita Santi; Elisabeth J Rushing; Cara H Olsen; Robert F Keating; Gilbert Vezina; Nadja Kadom; Roger J Packer
Journal:  J Neurooncol       Date:  2009-06-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.